232 related articles for article (PubMed ID: 23276997)
1. Patents of bio-active compounds based on computer-aided drug discovery techniques.
Prado-Prado F; Garcia-Mera X; Rodriguez-Borges JE; Concu R; Perez-Montoto LG; Gonzalez-Diaz H; Duardo-Sanchez A
Front Biosci (Elite Ed); 2013 Jan; 5(2):399-407. PubMed ID: 23276997
[TBL] [Abstract][Full Text] [Related]
2. Current topics on software use in medicinal chemistry: intellectual property, taxes, and regulatory issues.
Duardo-Sánchez A; Patlewicz G; López-Díaz A
Curr Top Med Chem; 2008; 8(18):1666-75. PubMed ID: 19075773
[TBL] [Abstract][Full Text] [Related]
3. Legal issues for chem-bioinformatics models.
Duardo-Sanchez A; Gonzalez-Diaz H
Front Biosci (Elite Ed); 2013 Jan; 5(1):361-74. PubMed ID: 23276995
[TBL] [Abstract][Full Text] [Related]
4. Tools, techniques, organisation and culture of the CADD group at Sygnature Discovery.
St-Gallay SA; Sambrook-Smith CP
J Comput Aided Mol Des; 2017 Mar; 31(3):305-308. PubMed ID: 27798721
[TBL] [Abstract][Full Text] [Related]
5. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
6. Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift.
Usha T; Shanmugarajan D; Goyal AK; Kumar CS; Middha SK
Curr Top Med Chem; 2017; 17(30):3296-3307. PubMed ID: 29295698
[TBL] [Abstract][Full Text] [Related]
7. Computational chemistry at Janssen.
van Vlijmen H; Desjarlais RL; Mirzadegan T
J Comput Aided Mol Des; 2017 Mar; 31(3):267-273. PubMed ID: 27995515
[TBL] [Abstract][Full Text] [Related]
8. Computer-aided drug design at Boehringer Ingelheim.
Muegge I; Bergner A; Kriegl JM
J Comput Aided Mol Des; 2017 Mar; 31(3):275-285. PubMed ID: 27650777
[TBL] [Abstract][Full Text] [Related]
9. Computational Methodologies in the Exploration of Marine Natural Product Leads.
Pereira F; Aires-de-Sousa J
Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30011882
[TBL] [Abstract][Full Text] [Related]
10. Software and resources for computational medicinal chemistry.
Liao C; Sitzmann M; Pugliese A; Nicklaus MC
Future Med Chem; 2011 Jun; 3(8):1057-85. PubMed ID: 21707404
[TBL] [Abstract][Full Text] [Related]
11. Editorial: The Expanding Landscape of Graph Theoretic Molecular Descriptors: Development, Gradual Diversification of Descriptor Space, and Applications in QSAR/ QMSA and New Drug Discovery.
Basak SC
Curr Comput Aided Drug Des; 2017; 13(3):172-176. PubMed ID: 29517467
[No Abstract] [Full Text] [Related]
12. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
13. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
Thompson KH; Orvig C
Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
[TBL] [Abstract][Full Text] [Related]
14. Modeling of activity landscapes for drug discovery.
Bajorath J
Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
[TBL] [Abstract][Full Text] [Related]
15. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic applications of click chemistry for pharmaceutical drug discovery and drug delivery.
Meghani NM; Amin HH; Lee BJ
Drug Discov Today; 2017 Nov; 22(11):1604-1619. PubMed ID: 28754291
[TBL] [Abstract][Full Text] [Related]
17. Editorial: Descriptor Spaces for QSAR: Delving into the History of the Expanding Frontier.
Basak SC; Mishra RK
Curr Comput Aided Drug Des; 2017; 13(1):4-7. PubMed ID: 28222673
[No Abstract] [Full Text] [Related]
18. Parallel worlds of public and commercial bioactive chemistry data.
Lipinski CA; Litterman NK; Southan C; Williams AJ; Clark AM; Ekins S
J Med Chem; 2015 Mar; 58(5):2068-76. PubMed ID: 25415348
[TBL] [Abstract][Full Text] [Related]
19. On the contribution of molecular topology to drug design and discovery.
Gálvez J; García-Doménech R
Curr Comput Aided Drug Des; 2010 Dec; 6(4):252-68. PubMed ID: 20883200
[TBL] [Abstract][Full Text] [Related]
20. Using Data Exclusivity Grants to Incentivize Cumulative Innovation of Biologics' Manufacturing Processes.
Levi EL
Am Univ Law Rev; 2017; 66(3):911-70. PubMed ID: 28233970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
